Big Gain For Opiant Pharmaceuticals, Inc.
Mon, Nov 14, 2022 at 07:47 PM
Opiant Pharmaceuticals, Inc. (OPNT:NASDAQ) rocketted at $20.1, representing a gain of 113.8%. On Mon, Nov 14, 2022, OPNT:NASDAQ hit a New 2-Week High of $20.1. The stock appeared on our News Catalysts scanner on Mon, Nov 14, 2022 at 11:12 AM in the 'ACQUISITION' category. From Mon, Oct 31, 2022, the stock recorded 60.00% Up Days and 27.27% Green Days
About Opiant Pharmaceuticals, Inc. (OPNT:NASDAQ)
Opiant Pharmaceuticals Inc is a specialty pharmaceutical company. The Company develops opioid pharmacological treatments for substance use, addictive and eating disorders.
Top 10 Gainers:
- Opiant Pharmaceuticals, Inc. (OPNT:NASDAQ), 113.83%
- Freight Technologies Inc Com (FRGT:NASDAQ), 113.56%
- FedNat Holding Company (FNHC:NASDAQ), 108.33%
- ToughBuilt Industries, Inc. (TBLT:NASDAQ), 72.27%
- Exela Technologies, Inc. (XELA:NASDAQ), 45.61%
- Porch Group Inc. (PRCH:NASDAQ), 37.25%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 36.11%
- Clovis Oncology, Inc. (CLVS:NASDAQ), 32.62%
- Getty Images Holdings Inc. Class A (GETY:NYSE), 31.26%
- XL Group Ltd (XL:NYSE), 30.91%